Related references
Note: Only part of the references are listed.Chemopreventive and therapeutic potential of curcumin in esophageal cancer: Current and future status
AmirReza Hesari et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Genetic and epigenetic contribution to astrocytic gliomas pathogenesis
Pouria Khani et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Stem Cell Therapy: A New Therapeutic Option for Cardiovascular Diseases
Nasser Hashemi Goradel et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Mesenchymal stem cells: A new platform for targeting suicide genes in cancer
Rana Moradian Tehrani et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Therapeutic application of multipotent stem cells
Hamed Mirzaei et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
GD2-targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma
Sharareh Gholamin et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer
Abdullah Moridikia et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
The therapeutic potential of human adipose-derived mesenchymal stem cells producing CXCL10 in a mouse melanoma lung metastasis model
Harried Mirzaei et al.
CANCER LETTERS (2018)
Circulating microRNAs as diagnostic and therapeutic biomarkers in gastric and esophageal cancers
Leila Jamali et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1
Lin Wang et al.
ONCOTARGET (2016)
Mesenchymal stem cell: a new horizon in cancer gene therapy
M. Mohammadi et al.
CANCER GENE THERAPY (2016)
MicroRNA as Regulators of Cancer Stem Cells and Chemoresistance in Colorectal Cancer
Xiaoming Liu et al.
CURRENT CANCER DRUG TARGETS (2016)
Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents
Hamed Mirzaei et al.
CURRENT MEDICINAL CHEMISTRY (2016)
The Plasma microRNA miR-1914*and-1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-Regulating NFIX
J. Hu et al.
CURRENT MOLECULAR MEDICINE (2016)
Deciphering biological characteristics of tumorigenic subpopulations in human colorectal cancer reveals cellular plasticity
Hamed Mirzaei et al.
JOURNAL OF RESEARCH IN MEDICAL SCIENCES (2016)
Four microRNAs Signature for Survival Prognosis in Colon Cancer using TCGA Data
Jian Xu et al.
SCIENTIFIC REPORTS (2016)
Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells
Anna-Maria Pehserl et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer
T. F. Hansen et al.
BRITISH JOURNAL OF CANCER (2015)
MiR-199a-5p and miR-375 affect colon cancer cell sensitivity to cetuximab by targeting PHLPP1
Paula Mussnich et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma
Heba W. Z. Khella et al.
MOLECULAR THERAPY (2015)
miR-191 promotes tumorigenesis of human colorectal cancer through targeting C/EBPβ
Xiao-Fei Zhang et al.
ONCOTARGET (2015)
miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1
Zhiheng Chen et al.
ONCOTARGET (2015)
Radiation and SN38 treatments modulate the expression of microRNAs, cytokines and chemokines in colon cancer cells in a p53-directed manner
Surajit Pathak et al.
ONCOTARGET (2015)
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab
Jitka Mlcochova et al.
ONCOTARGET (2015)
MicroRNA-195 Chemosensitizes Colon Cancer Cells to the Chemotherapeutic Drug Doxorubicin by Targeting the First Binding Site of BCL2L2 mRNA
Juan Qu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
Circulating microRNA expressions in colorectal cancer as predictors of response to chemotherapy
Jian Zhang et al.
ANTI-CANCER DRUGS (2014)
MicroRNA Signature in Metastatic Colorectal Cancer Patients Treated With Anti-EGFR Monoclonal Antibodies
Federico Cappuzzo et al.
CLINICAL COLORECTAL CANCER (2014)
MicroRNA-147 Induces a Mesenchymal-To-Epithelial Transition (MET) and Reverses EGFR Inhibitor Resistance
Chang Gong Lee et al.
PLOS ONE (2014)
miR-345 in Metastatic Colorectal Cancer: A Non-Invasive Biomarker for Clinical Outcome in Non-KRAS Mutant Patients Treated with 3rd Line Cetuximab and Irinotecan
Jakob V. Schou et al.
PLOS ONE (2014)
MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression
Lekun Fang et al.
ONCOTARGET (2014)
Serum miR-19a Predicts Resistance to FOLFOX Chemotherapy in Advanced Colorectal Cancer Cases
Qi Chen et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
miR-125a/b Regulates the Activation of Cancer Stem Cells in Paclitaxel-resistant Colon Cancer
Jixiang Chen et al.
CANCER INVESTIGATION (2013)
High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer
Mads H. Rasmussen et al.
MOLECULAR ONCOLOGY (2013)
MicroRNA-18a Attenuates DNA Damage Repair through Suppressing the Expression of Ataxia Telangiectasia Mutated in Colorectal Cancer
Chung-Wah Wu et al.
PLOS ONE (2013)
MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer
X. T. Xu et al.
BRITISH JOURNAL OF CANCER (2012)
MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGF beta R2) in colon cancer cells
Yingjie Yu et al.
CARCINOGENESIS (2012)
Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells
Ken Kurokawa et al.
JOURNAL OF GASTROENTEROLOGY (2012)
High Let-7a MicroRNA Levels in KRAS-Mutated Colorectal Carcinomas May Rescue Anti-EGFR Therapy Effects in Patients with Chemotherapy-Refractory Metastatic Disease
Annamaria Ruzzo et al.
ONCOLOGIST (2012)
Ascl2 Knockdown Results in Tumor Growth Arrest by miRNA-302b-Related Inhibition of Colon Cancer Progenitor Cells
Rong Zhu et al.
PLOS ONE (2012)
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness?
S. Caruso et al.
ONCOGENESIS (2012)
MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line
Huanle Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
miR-93 suppresses proliferation and colony formation of human colon cancer stem cells
Xiao-Feng Yu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cells
Esmerina Tili et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells
Bo Song et al.
MOLECULAR CANCER (2010)
Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells
B. Song et al.
ONCOGENE (2009)
MiR-24 Tumor Suppressor Activity Is Regulated Independent of p53 and through a Target Site Polymorphism
Prasun J. Mishra et al.
PLOS ONE (2009)
Overlapping expression of microRNAs in human embryonic colon and colorectal cancer
Mariano Monzo et al.
CELL RESEARCH (2008)
microRNAs as oncogenes and tumor suppressors
Baohong Zhang et al.
DEVELOPMENTAL BIOLOGY (2007)
Share Paper
